MovDisordV3, Ncbi, Merge, bibRecord, 000F35

Development of Parkinson's disease in patients with blepharospasm.

Identifieur interne : 000F35 ( Ncbi/Merge ); précédent : 000F34; suivant : 000F36

Development of Parkinson's disease in patients with blepharospasm.

Auteurs : Federico Micheli [Argentine] ; María Clara Scorticati ; Silvia Folgar ; Emilia Gatto

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.

RBID : pubmed:15372598

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Botulinum Toxins, Type A (therapeutic use), Brain (pathology), Brain (physiopathology), Brain (radiography), Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Meige Syndrome (diagnosis), Meige Syndrome (drug therapy), Meige Syndrome (epidemiology), Neuromuscular Agents (therapeutic use), Parkinson Disease (diagnosis), Parkinson Disease (epidemiology), Parkinson Disease (physiopathology), Severity of Illness Index, Tomography, X-Ray Computed.
MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A, Neuromuscular Agents.
- diagnosis : Meige Syndrome, Parkinson Disease.
- drug therapy : Meige Syndrome.
- epidemiology : Meige Syndrome, Parkinson Disease.
- pathology : Brain.
- physiopathology : Brain, Parkinson Disease.
- radiography : Brain.
- Aged, Aged, 80 and over, Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Severity of Illness Index, Tomography, X-Ray Computed.

Abstract

The liability to develop parkinsonian symptoms was evaluated in 105 outpatients with idiopathic blepharospasm (IBS; 54 cases) or IBS associated to oromandibular dystonia (Meige's syndrome; 51 cases) mean age 70.3 +/- 9.6 years, and compared with an age- and sex-matched population. Eleven patients developed Parkinson's disease in the blepharospasm group, whereas only 2 of 105 patients were affected in the control group. Our results suggest that patients with IBS either isolated or associated with oromandibular dystonia are more prone to develop parkinsonian symptoms.

DOI: 10.1002/mds.20084
PubMed: 15372598

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003353
to stream PubMed, to step Curation: 003353
to stream PubMed, to step Checkpoint: 003496

Links to Exploration step

pubmed:15372598

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of Parkinson's disease in patients with blepharospasm.</title>
<author><name sortKey="Micheli, Federico" sort="Micheli, Federico" uniqKey="Micheli F" first="Federico" last="Micheli">Federico Micheli</name>
<affiliation wicri:level="1"><nlm:affiliation>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina. fmicheli@fibertel.com.ar</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scorticati, Maria Clara" sort="Scorticati, Maria Clara" uniqKey="Scorticati M" first="María Clara" last="Scorticati">María Clara Scorticati</name>
</author>
<author><name sortKey="Folgar, Silvia" sort="Folgar, Silvia" uniqKey="Folgar S" first="Silvia" last="Folgar">Silvia Folgar</name>
</author>
<author><name sortKey="Gatto, Emilia" sort="Gatto, Emilia" uniqKey="Gatto E" first="Emilia" last="Gatto">Emilia Gatto</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15372598</idno>
<idno type="pmid">15372598</idno>
<idno type="doi">10.1002/mds.20084</idno>
<idno type="wicri:Area/PubMed/Corpus">003353</idno>
<idno type="wicri:Area/PubMed/Curation">003353</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003496</idno>
<idno type="wicri:Area/Ncbi/Merge">000F35</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Development of Parkinson's disease in patients with blepharospasm.</title>
<author><name sortKey="Micheli, Federico" sort="Micheli, Federico" uniqKey="Micheli F" first="Federico" last="Micheli">Federico Micheli</name>
<affiliation wicri:level="1"><nlm:affiliation>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina. fmicheli@fibertel.com.ar</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scorticati, Maria Clara" sort="Scorticati, Maria Clara" uniqKey="Scorticati M" first="María Clara" last="Scorticati">María Clara Scorticati</name>
</author>
<author><name sortKey="Folgar, Silvia" sort="Folgar, Silvia" uniqKey="Folgar S" first="Silvia" last="Folgar">Silvia Folgar</name>
</author>
<author><name sortKey="Gatto, Emilia" sort="Gatto, Emilia" uniqKey="Gatto E" first="Emilia" last="Gatto">Emilia Gatto</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Brain (radiography)</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Meige Syndrome (diagnosis)</term>
<term>Meige Syndrome (drug therapy)</term>
<term>Meige Syndrome (epidemiology)</term>
<term>Neuromuscular Agents (therapeutic use)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Severity of Illness Index</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Meige Syndrome</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Meige Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Meige Syndrome</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="radiography" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Severity of Illness Index</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The liability to develop parkinsonian symptoms was evaluated in 105 outpatients with idiopathic blepharospasm (IBS; 54 cases) or IBS associated to oromandibular dystonia (Meige's syndrome; 51 cases) mean age 70.3 +/- 9.6 years, and compared with an age- and sex-matched population. Eleven patients developed Parkinson's disease in the blepharospasm group, whereas only 2 of 105 patients were affected in the control group. Our results suggest that patients with IBS either isolated or associated with oromandibular dystonia are more prone to develop parkinsonian symptoms.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15372598</PMID>
<DateCreated><Year>2004</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>11</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>19</Volume>
<Issue>9</Issue>
<PubDate><Year>2004</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Development of Parkinson's disease in patients with blepharospasm.</ArticleTitle>
<Pagination><MedlinePgn>1069-1072</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The liability to develop parkinsonian symptoms was evaluated in 105 outpatients with idiopathic blepharospasm (IBS; 54 cases) or IBS associated to oromandibular dystonia (Meige's syndrome; 51 cases) mean age 70.3 +/- 9.6 years, and compared with an age- and sex-matched population. Eleven patients developed Parkinson's disease in the blepharospasm group, whereas only 2 of 105 patients were affected in the control group. Our results suggest that patients with IBS either isolated or associated with oromandibular dystonia are more prone to develop parkinsonian symptoms.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Micheli</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Programa de Parkinson y Movimientos Anormales, Instituto de Neurociencias, Hospital de Clínicas José de San Martín, Buenos Aires, Argentina. fmicheli@fibertel.com.ar</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Scorticati</LastName>
<ForeName>María Clara</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Folgar</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gatto</LastName>
<ForeName>Emilia</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009465">Neuromuscular Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber>
<NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019274">Botulinum Toxins, Type A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008538">Meige Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009465">Neuromuscular Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15372598</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20084</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Argentine</li>
</country>
</list>
<tree><noCountry><name sortKey="Folgar, Silvia" sort="Folgar, Silvia" uniqKey="Folgar S" first="Silvia" last="Folgar">Silvia Folgar</name>
<name sortKey="Gatto, Emilia" sort="Gatto, Emilia" uniqKey="Gatto E" first="Emilia" last="Gatto">Emilia Gatto</name>
<name sortKey="Scorticati, Maria Clara" sort="Scorticati, Maria Clara" uniqKey="Scorticati M" first="María Clara" last="Scorticati">María Clara Scorticati</name>
</noCountry>
<country name="Argentine"><noRegion><name sortKey="Micheli, Federico" sort="Micheli, Federico" uniqKey="Micheli F" first="Federico" last="Micheli">Federico Micheli</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F35 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000F35 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15372598
   |texte=   Development of Parkinson's disease in patients with blepharospasm.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15372598" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Development of Parkinson's disease in patients with blepharospasm.

Development of Parkinson's disease in patients with blepharospasm.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki